CHRISTINA O'BRIEN: Open Payments
NPI 1215451752 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,648 in 71 payments from 16 companies in 2025. Trend: 2023 $1,762 · 2024 $1,208 · 2025 $1,648
Food & beverage: $1,648
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $375 |
| Organon LLC | 3 | $183 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $142 |
| Arcutis Biotherapeutics, Inc. | 10 | $137 |
| UCB, Inc. | 8 | $135 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| Amgen Inc. | 4 | $98 |
| GENZYME CORPORATION | 4 | $96 |
| LEO Pharma Inc. | 3 | $94 |
| Incyte Corporation | 3 | $87 |
Products named: BOTOX, VTAMA, Zoryve, Bimzelx, RINVOQ, COSENTYX, OTEZLA, DUPIXENT.
Industry payments across VA — which companies pay providers there.
